Is This COVID-19 Vaccine Trial a Promising Start or a Dead End?
TWO PATHS
One scientist says it’s “about as promising as one could expect,” while another worries it “may not alter the course of disease.”
Getty
The pharmaceutical firm Moderna has reported good results so far in trials of its novel-coronavirus vaccine, inspiring cautious optimism in scientists scrambling to contain the damage from the ongoing pandemic.
But these same scientists warn against getting too excited about early results, however positive. The world could still be a long way from having a working vaccine for SARS-CoV-2, to say nothing of deploying that vaccine on a large scale.
Welcome to Rabbit Hole, where we dive deep on the biggest story. It’s for Beast Inside members only. Join up today.
Got a tip? Send it to The Daily Beast here.
